A Novel Player in Atherosclerotic Diseases in Renal Patients: Tumor Necrosis Factor-like Weak Inducer of Apoptosis (TWEAK)

Artículo de revista

A Novel Player in Atherosclerotic Diseases in Renal Patients: Tumor Necrosis Factor-like Weak Inducer of Apoptosis (TWEAK)

Özkan GÜNGÖR et al · Turkish Society of Nephrology · 2019

Acceso abierto al texto completo

Lectura rápida. Revisá los datos básicos del recurso y luego accedé al contenido desde el botón principal. En esta ficha solo se muestra la información necesaria para identificar la obra, citarla y abrirla.

Autor / responsable

Özkan GÜNGÖR et al

Editorial

Turkish Society of Nephrology

Año

2019

ISSN

2667-4440

ISSN

2667-4440

Idioma

eng

Publicación seriada

"ONE HUNDRED AND THIRTY-FIVE HOURS UNDER THE RUIN : A CASE WITH TRAUMATIC RHABDOMYOLYSIS IN GÖLCÜK EARTHQUAKE"

Esta publicación seriada contiene 1.344 contenidos relacionados.

Ver contenidos

Acceso al recurso

Entrá al contenido desde la opción principal o elegí otra fuente disponible.

Acceso principal

Acceso abierto al texto completo

Texto completo identificado como acceso abierto.

Abrir texto

Resumen

Descripción general del contenido del recurso.

Cardiovascular disease is common in patients with chronic kidney disease. Atherosclerosis has a very important role in pathogenesis of cardiovascular diseases. Tumor Necrosis factor- Like Weak Inducer of Apoptosis (TWEAK) is a glycoprotein that belongs to the TNF superfamily. TWEAK plays important roles in cellular proliferation, growth, migration, osteoclastogenesis, angiogenesis and apoptosis. In the recent years, TWEAK has been suggested to have a role in atherosclerosis. While it is known that TWEAK levels are decreased in patient with renal failure, its association with atherosclerosis is not well-defi ned. This review focuses on the association of TWEAK with atherosclerosis in patients with renal patients.

Cómo citar

Elegí el formato que necesitás y copiá la referencia al portapapeles.

APA 7

al, Ö. G. E. (2019). A Novel Player in Atherosclerotic Diseases in Renal Patients: Tumor Necrosis Factor-like Weak Inducer of Apoptosis (TWEAK). https://turkjnephrol.org/index.php/pub/article/view/896

MLA

al, Özkan GÜNGÖR et. "A Novel Player in Atherosclerotic Diseases in Renal Patients: Tumor Necrosis Factor-like Weak Inducer of Apoptosis (TWEAK)." 2019. https://turkjnephrol.org/index.php/pub/article/view/896.

Chicago

al, Özkan GÜNGÖR et. 2019. "A Novel Player in Atherosclerotic Diseases in Renal Patients: Tumor Necrosis Factor-like Weak Inducer of Apoptosis (TWEAK).". https://turkjnephrol.org/index.php/pub/article/view/896.

Harvard

al, Ö. G. E. 2019, A Novel Player in Atherosclerotic Diseases in Renal Patients: Tumor Necrosis Factor-like Weak Inducer of Apoptosis (TWEAK), Turkish Society of Nephrology, available at: https://turkjnephrol.org/index.php/pub/article/view/896 [Accessed 29 Jun. 2026].

Compartir e imprimir

Guardá la ficha, copiá su enlace permanente o imprimila como PDF.

Exportar referencia

Si usás un gestor bibliográfico, podés exportar el registro en los formatos más comunes.

RIS BibTeX

Detalles del recurso

Información bibliográfica útil para confirmar que se trata del material correcto.

Título: A Novel Player in Atherosclerotic Diseases in Renal Patients: Tumor Necrosis Factor-like Weak Inducer of Apoptosis (TWEAK)

Autor / colaboradores: Özkan GÜNGÖR et al

Editorial: Turkish Society of Nephrology

Año de publicación: 2019

ISSN: 2667-4440

ISSN: 2667-4440

Idioma: eng

Materias

Explorá otros recursos relacionados a partir de estas materias.

Kidney; TWEAK; Atherosclerosis